Slow IV push: used for lower doses, given over several minutes
It is not approved by the FDA for clinical use, diagnostics, or therapeutic procedures in humans or animals
The FDA has not approved these peptides for obesity treatment (FDA guidance on unapproved peptides)
NNMT has been explored as a target in obesity, insulin resistance, and age-related metabolic decline, supporting the rationale for translational research into body composition and performance contexts (Kannt & Pfenninger, Frontiers in Physiology )
There is no legitimate compounding or clinical access pathway in U.S
Para ello utilizamos ingredientes trados directamente de Grecia como nuestros quesos DOP o el yogurt, ingredientes clave de la cocina griega